Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | QL1203 |
Synonyms | |
Therapy Description |
QL1203 is a monoclonal antibody directed against EGFR, which potentially inhibits tumor growth (PMID: 35845484). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
QL1203 | QL-1203|QL 1203 | EGFR Antibody 60 | QL1203 is a monoclonal antibody directed against EGFR, which potentially inhibits tumor growth (PMID: 35845484). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|